Anebulo Pharmaceuticals Inc
(ANEB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,158 | -8,485 | -6,340 | -4,664 | -2,201 |
| Depreciation Amortization | 17 | 382 | 365 | 119 | 60 |
| Accounts receivable | 63 | -73 | N/A | -31 | -245 |
| Accounts payable and accrued liabilities | 383 | 68 | 271 | 126 | 96 |
| Other Working Capital | 630 | 306 | 171 | 597 | 164 |
| Other Operating Activity | -209 | 1,452 | 835 | 757 | 437 |
| Operating Cash Flow | $-1,273 | $-6,350 | $-4,698 | $-3,096 | $-1,690 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 15,000 | 15,000 | 15,000 | N/A |
| Other Financing Activity | 0 | -117 | -117 | 0 | 0 |
| Financing Cash Flow | $N/A | $14,883 | $14,883 | $15,000 | $N/A |
| Beginning Cash Position | 11,628 | 3,094 | 3,094 | 3,094 | 3,094 |
| End Cash Position | 10,355 | 11,628 | 13,280 | 14,999 | 1,404 |
| Net Cash Flow | $-1,273 | $8,534 | $10,186 | $11,904 | $-1,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,273 | -6,350 | -4,698 | -3,096 | -1,690 |
| Free Cash Flow | -1,273 | -6,350 | -4,698 | -3,096 | -1,690 |